文献速递膀胱癌与上尿路尿路上皮癌前列腺增生与排尿功能障碍泌尿系感染

神经泌尿功能障碍患者初始评估中膀胱冲洗细胞学的价值:做还是不做?

Bladder washing cytology in the initial evaluation of patients with neuro-urological disorders: to do or not to do?
PubMed 文献 · BJU Int · 2026-08-16

这项前瞻性横断面研究纳入2018至2023年因下尿路症状转诊至神经泌尿科并接受尿道膀胱镜(UC)和膀胱冲洗细胞学(BWC)的581例神经疾病患者,评估BWC在初始评估中的诊断增益。UC单独检出17例(2.9%)可疑肿瘤并手术,BWC在UC无异常时仅检出3例(0.5%);最终8例(1.4%,95%CI 0.6-2.7%)有相关组织学发现,均由UC初始识别。BWC相对UC的敏感性0%(95%CI 0.0-36.9%),特异性99.7%(95%CI 98.7-99.9%);加做BWC使费用增加22.8%而未改善肿瘤检出。

要点

  • UC单独检出17例(2.9%)可疑肿瘤,BWC在UC无异常时仅检出3例(0.5%)。
  • 最终8例(1.4%)相关组织学发现均由UC初始识别,BWC无真阳性。
  • BWC相对UC敏感性0%、特异性99.7%,加做使费用增加22.8%。

核心结论

  • 在神经泌尿功能障碍患者的初始评估中,UC之外加做BWC缺乏依据,因经尿道膀胱手术决策基于UC发现。
  • 省略BWC可节省相关费用而不损害患者安全。

研究设计与样本

  • 前瞻性横断面研究,连续纳入2018至2023年因下尿路症状转诊至神经泌尿科并接受UC和BWC的神经疾病患者581例,其中女性274例(47.2%)。

主要发现

  • UC单独检出17例(2.9%)可疑肿瘤并导致手术干预,BWC在UC无异常时检出3例(0.5%)。
  • 经尿道膀胱手术后相关组织学发现共8例(1.4%,95%CI 0.6-2.7%):角化性鳞状化生2例、非肌层浸润性尿路上皮癌6例,均由UC初始识别。
  • 3例拒绝手术,其中2例BWC阳性但UC无异常。
  • BWC相对UC的敏感性0%(95%CI 0.0-36.9%),特异性99.7%(95%CI 98.7-99.9%)。
  • 加做BWC使费用增加22.8%而未改善肿瘤检出。

临床怎么用

  • 神经泌尿功能障碍患者初始评估可仅行UC,不加做BWC,以UC发现决定是否行经尿道膀胱手术。
  • 省略BWC可节省费用且不损害患者安全。

局限性

  • 主要局限性为BWC缺乏真阳性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate if bladder washing cytology (BWC) provides a diagnostic benefit in the initial evaluation of patients with neuro-urological disorders. PATIENTS AND METHODS: This prospective cross-sectional study investigated a consecutive series of patients with lower urinary tract symptoms referred for neuro-urological evaluation at our department of neuro-urology who underwent urethro-cystoscopy (UC) and BWC from 2018 to 2023. RESULTS: Among 581 neurological patients, 274 (47.2%) were females. Tumour-suspicious findings leading to surgical intervention were detected in 17 (2.9%) by UC alone and in three (0.5%) by BWC but unsuspicious UC, respectively. Overall, relevant histological findings after transurethral bladder surgery (TUBS) were detected in eight (1.4%, 95% confidence interval [CI] 0.6-2.7%) patients: keratinising squamous metaplasia (two) and non-muscle-invasive urothelial carcinoma (six), all were initially identified by UC. Three patients refused surgery, two of whom had positive BWC without suspicious lesion in UC. Sensitivity and specificity of BWC referenced to UC alone were 0% (95% CI 0.0-36.9%) and 99.7% (95% CI 98.7-99.9%), respectively. Adding BWC to UC increased costs by 22.8% without improving tumour detection. The main study limitation was the lack of true positives in BWC. CONCLUSIONS: Bladder washing cytology in addition to UC is not justified in the initial evaluation of patients with neuro-urological disorders as decision making regarding TUBS is based on UC findings. Moreover, omission of BWC saves relevant costs without compromising patient safety.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Lehner F, Dugas S, Birkhäuser V, et al. Bladder washing cytology in the initial evaluation of patients with neuro-urological disorders: to do or not to do? BJU Int. 2026. PMID: 42604853. doi:10.1111/bju.70422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。